Avilex Pharma - Customer's story The first-in-human Phase 1 clinical trial of Avilex Pharma’s lead candidate AVLX-144 was conducted successfully in collaboration with Clinical Research Services Turku (CRST) in Finland. During the course of the Phase I study, AVLX-144 was…

CRST collaborates with the local Alzheimer associations CRST has been collaborating with the local associations of The Alzheimer Society of Finland for several years. The Alzheimer Society of Finland is a non-profit organisation providing help and assistance for people with Alzheimer's disease…

CRST is arranging a crowdfunding share emission together with Invesdor Nordics From its inception as a company, CRST has been aiming to grow profitably. After seven years of profitable growth and after reaching a turnover of €3,1M (in 2020), planning…